Nutritional advice to breast cancer survivors

Supportive Care in Cancer

Volumn 18, Issue SUPPL. 2, 2010, Pages

  Pasanisi, Patrizia ^a   Villarini, Anna ^a   Bruno, Eleonora ^a   Raimondi, Milena ^a   Gargano, Giuliana ^a   Berrino, Franco ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Breast cancer; Diet; Hormonal and metabolic factors; Prognosis

Indexed keywords

ANDROGEN; ESTROGEN; INSULIN; SEX HORMONE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ANDROGEN BLOOD LEVEL; BREAST CANCER; CANCER CELL; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CANCER SURVIVOR; CELL PROLIFERATION; CLINICAL TRIAL; CONFERENCE PAPER; DIETARY INTAKE; ESTROGEN BLOOD LEVEL; EVENT FREE SURVIVAL; FAT INTAKE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIFESTYLE; MEDITERRANEAN DIET; MENARCHE; MENSTRUAL CYCLE; METABOLIC SYNDROME X; NUTRITION; OBESITY; PHYSICAL ACTIVITY; POSTMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; WEIGHT GAIN;

BREAST NEOPLASMS; COUNSELING; DIETARY FATS; FEMALE; GONADAL STEROID HORMONES; HUMANS; INSULIN-LIKE GROWTH FACTOR I; METABOLIC SYNDROME X; NEOPLASM RECURRENCE, LOCAL; PATIENT EDUCATION AS TOPIC; RISK REDUCTION BEHAVIOR; SEDENTARY LIFESTYLE; SURVIVORS;

EID: 80655145509     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-009-0701-8     Document Type: Conference Paper

References (79)

1. World Cancer Research Fund, American Institute for Cancer Research (2007) Food, nutrition, physical activity and the prevention of cancer: a global perspective. AICR, Washington
2. Berrino F, Villarini A, De Petris M, Raimondi M, Pasanisi P (2006) Adjuvant diet to improve hormonal and metabolic factors affecting breast cancer prognosis. Ann N Y Acad Sci 1089:110-118. doi:10.1196/annals.1386.023 (Pubitemid 47092078)
3. Vona-Davis L, Howard-McNatt M, Rose DP (2007) Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer. Obes Rev 8:395-408. doi:10.1111/j.1467-789X.2007.00396.x (Pubitemid 47283945)
4. Vainio H, Bianchini F (2002) Weight control and physical activity. IARC Handbooks of cancer prevention, vol 6. IARC, Lyon
5. Lahmann PH, Hoffmann K, Allen N et al (2004) Body size and breast cancer risk: findings from the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer 111:762-771. doi:10.1002/ijc.20315 (Pubitemid 39062901)
6. Baer HJ, Colditz GA, Rosner B et al (2005) Body fatness during childhood and adolescence and incidence of breast cancer in premenopausal women: a prospective cohort study. Breast Cancer Res 7: R314-R325. doi:10.1186/bcr998
7. Tehard B, Kaaks R, Clavel-Chapelon F (2005) Body silhouette, menstrual function at adolescence and breast cancer risk in the E3N cohort study. Br J Cancer 92:2042-2048. doi:10.1038/sj. bjc.6602620
8. Lahmann PH, Schulz M, Hoffmann K et al (2005) Long-term weight change and breast cancer risk: the European prospective investigation into cancer and nutrition (EPIC). Br J Cancer 93:582-589. doi:10.1038/sj.bjc.6602763 (Pubitemid 43080003)
9. Berclaz G, Li S, Price KN et al (2004) Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience. Ann Oncol 15:875-884. doi: 10.1093/annonc/mdh222 (Pubitemid 39004342)
10. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U. S. adults. N Engl J Med 348:1625-1638. doi: 10.1056/NEJMoa021423 (Pubitemid 36459468)
11. Dawood S, Broglio K, Gonzalez-Angulo AM et al (2008) Prognostic value of body mass index in locally advanced breast cancer. Clin Cancer Res 14:1718-1725. doi:10.1158/1078-0432. CCR-07-1479
12. Griggs JJ, Sabel MS (2008) Obesity and cancer treatment: weighing the evidence. J Clin Oncol 26:4060-4062. doi:10.1200/JCO.2008.17.4250
13. Kroenke CH, Chen WY, Rosner B, Holmes MD (2005) Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol 23:1370-1378. doi:10.1200/JCO.2005.01.079
14. Chlebowski RT, Blackburn GL, Thomson CA et al (2006) Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study. J Natl Cancer Inst 98:1767-1776
15. Litton JK, Gonzalez-Angulo AM, Warneke CL et al (2008) Relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancer. J Clin Oncol 26:4072-4077. doi:10.1200/JCO.2007.14. 4527
16. Camoriano JK, Loprinzi CL, Ingle JN, Therneau TM, Krook JE, Veeder MH (1990) Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer. J Clin Oncol 8:1327-1334
17. Chlebowski RT, Weiner JM, Reynolds R, Luce J, Bulcavage L, Bateman JR (1986) Long-term survival following relapse after 5-FU but not CMF adjuvant breast cancer therapy. Breast Cancer Res Treat 7:23-30. doi:10.1007/BF01886732 (Pubitemid 17173378)
18. Cavalieri E, Frenkel K, Liehr JG, Rogan E, Roy D (2000) Estrogens as endogenous genotoxic agents-DNA adducts and mutations. J Natl Cancer Inst Monogr 27:75-93
19. Creighton CJ, Casa A, Lazard Z et al (2008) Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosis. J Clin Oncol 26:4078-4085. doi: 10.1200/JCO.2007.13.4429
20. Griggs JJ, Sorbero ME, Lyman GH (2005) Undertreatment of obese women receiving breast cancer chemotherapy. Arch Intern Med 165:1267-1273. doi:10.1001/archinte.165.11.1267 (Pubitemid 40989591)
21. Phipps AI, Malone KE, Porter PL, Daling JR Li CI (2008) Body size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev 17:2078-2086. doi:10.1158/1055-9965. EPI-08-0206
22. Eliassen AH, Missmer SA, Tworoger SS et al (2006) Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst 98:1406-1415
23. Kaaks R, Rinaldi S, Key TJ et al (2005) Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer 12:1071-1082. doi:10.1677/erc.1.01038 (Pubitemid 41815798)
24. Kaaks R, Berrino F, Key T et al (2005) Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 97:755-765
25. Key T, Appleby P, Barnes I, Reeves G (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94:606-616
26. Micheli A, Muti P, Secreto G et al (2004) Endogenous sex hormones and subsequent breast cancer in premenopausal women. Int J Cancer 112:312-318. doi:10.1002/ijc.20403 (Pubitemid 39244371)
27. Rock CL, Flatt SW, Laughlin GA et al (2008) Reproductive steroid hormones and recurrence-free survival in women with a history of breast cancer. Cancer Epidemiol Biomarkers Prev 17:614-620. doi:10.1158/1055-9965. EPI-07-0761
28. Roy V, Perez EA (2006) New therapies in the treatment of breast cancer. Semin Oncol 33: S3-S8. doi:10.1053/j.seminoncol.2006.03.018
29. Berrino F, Pasanisi P, Bellati C et al (2005) Serum testosterone levels and breast cancer recurrence. Int J Cancer 113:499-502. doi:10.1002/ijc.20582 (Pubitemid 40038721)
30. Micheli A, Meneghini E, Secreto G et al (2007) Plasma testosterone and prognosis of postmenopausal breast cancer patients. J Clin Oncol 25:2685-2690. doi:10.1200/JCO.2006.09.0118 (Pubitemid 47123174)
31. Verheus M, Peeters PH, Rinaldi S et al (2006) Serum C-peptide levels and breast cancer risk: results from the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer 119:659-667. doi:10.1002/ijc.21861 (Pubitemid 43955721)
32. Gunter MJ, Hoover DR, Yu H et al (2009) Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 101:48-60. doi:10.1093/jnci/djn415
33. Kaaks R (1996) Nutrition, hormones, and breast cancer: is insulin the missing link? Cancer Causes Control 7:605-625. doi:10.1007/BF00051703 (Pubitemid 26377730)
34. Bruning PF, Bonfrer JM, van Noord PA, Hart AA, Jong-Bakker M, Nooijen WJ (1992) Insulin resistance and breast-cancer risk. Int J Cancer 52:511-516. doi:10.1002/ijc.2910520402
35. Goodwin PJ, Ennis M, Pritchard KI et al (2002) Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 20:42-51. doi:10.1200/JCO.20.1.42 (Pubitemid 34032594)
36. Conover CA (1996) Regulation and physiological role of insulinlike growth factor binding proteins. Endocr J 43(Suppl):S43-S48. doi:10.1507/endocrj.43. Suppl-S43
37. Dickson R (1996) Biochemical control of breast development. In: Harris JR, Lippman ME, Morrow M, Hellman S (eds) Diseases of the breast. Lippincott-Raven, Philadelphia, pp 15-25
38. Stewart CE, Rotwein P (1996) Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. Physiol Rev 76:1005-1026
39. Oh JS, Kucab JE, Bushel PR et al (2002) Insulin-like growth factor-1 inscribes a gene expression profile for angiogenic factors and cancer progression in breast epithelial cells. Neoplasia 4:204-217. doi:10.1038/sj.neo.7900229
40. Baxter RC, Butt AJ, Schedlich LJ, Martin JL (2000) Antiproliferative and pro-apoptotic activities of insulin-like growth factorbinding protein-3. Growth Horm IGF Res 10(Suppl A):S10-S11
41. Norat T, Dossus L, Rinaldi S et al (2007) Diet, serum insulin-like growth factor-I and IGF-binding protein-3 in European women. Eur J Clin Nutr 61:91-98. doi:10.1038/sj.ejcn. 1602494
42. Baglietto L, English DR, Hopper JL, Morris HA, Tilley WD, Giles GG (2007) Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer. Cancer Epidemiol Biomarkers Prev 16:763-768. doi:10.1158/1055- 9965. EPI-06-0960
43. Campagnoli C, Pasanisi P, Peris C, Berrino F (2008) Insulin-like growth factor-I and breast cancer: epidemiological and clinical data. In: Pasqualini JR (ed) Breast cancer: prognosis, treatment and prevention, 2nd edn. INFORMA-Healthcare, Paris
44. Rinaldi S, Toniolo P, Muti P et al (2005) IGF-I, IGFBP-3 and breast cancer in young women: a pooled re-analysis of three prospective studies. Eur J Cancer Prev 14:493-496. doi:10.1097/00008469-200512000-00001 (Pubitemid 41689647)
45. Pasanisi P, Venturelli E, Morelli D, Fontana L, Secreto G, Berrino F (2008) Serum insulin-like growth factor-I and platelet-derived growth factor as biomarkers of breast cancer prognosis. Cancer Epidemiol Biomarkers Prev 17:1719-1722. doi:10.1158/1055-9965. EPI-07-0654
46. Ford ES, Giles WH (2003) A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 26:575-581. doi:10.2337/diacare.26.3.575 (Pubitemid 36929310)
47. Moller DE, Kaufman KD (2005) Metabolic syndrome: a clinical and molecular perspective. Annu Rev Med 56:45-62. doi:10.1146/annurev. med.56.082103.104751
48. Beji NK, Reis N (2007) Risk factors for breast cancer in Turkish women: a hospital-based case-control study. Eur J Cancer Care (Engl) 16:178-184. doi:10.1111/j.1365-2354.2006.00711.x
49. Connolly BS, Barnett C, Vogt KN, Li T, Stone J, Boyd NF (2002) A meta-analysis of published literature on waist-to-hip ratio and risk of breast cancer. Nutr Cancer 44:127-138. doi:10.1207/S15327914NC4402-02
50. Furberg AS, Veierod MB, Wilsgaard T, Bernstein L, Thune I (2004) Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst 96:1152-1160
51. Goodwin PJ, Boyd NF, Hanna W et al (1997) Elevated levels of plasma triglycerides are associated with histologically defined premenopausal breast cancer risk. Nutr Cancer 27:284-292
52. Han C, Zhang HT, Du L et al (2005) Serum levels of leptin, insulin, and lipids in relation to breast cancer in china. Endocrine 26:9-24. doi:10.1385/ENDO:26:1:019
53. Michalaki V, Koutroulis G, Syrigos K, Piperi C, Kalofoutis A (2005) Evaluation of serum lipids and high-density lipoprotein subfractions (HDL2, HDL3) in postmenopausal patients with breast cancer. Mol Cell Biochem 268:19-24. doi:10.1007/s11010-005-2993-4 (Pubitemid 40287822)
54. Muti P, Quattrin T, Grant BJ et al (2002) Fasting glucose is a risk factor for breast cancer: a prospective study. Cancer Epidemiol Biomarkers Prev 11:1361-1368
55. Peeters PH, van Noord PA, Hoes AW, Fracheboud J, Gimbrere CH, Grobbee DE (2000) Hypertension and breast cancer risk in a 19-year follow-up study (the DOM cohort). Diagnostic investigation into mammarian cancer. J Hypertens 18:249-254. doi:10.1097/00004872-200018030-00002
56. Soler M, Chatenoud L, Negri E, Parazzini F, Franceschi S, la Vecchia C (1999) Hypertension and hormone-related neoplasms in women. Hypertension 34:320-325
57. Agnoli C, Berrino F, Abagnato CA, Muti P, Panico S, Crosignani P, Krogh V (2009) Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case-control study. Nutr Metab Cardiovasc Dis (in press)
58. Pasanisi P, Berrino F, De Petris M, Venturelli E, Mastroianni A, Panico S (2006) Metabolic syndrome as a prognostic factor for breast cancer recurrences. Int J Cancer 119:236-238. doi:10.1002/ijc.21812
59. Goodwin PJ, Ennis M, Bahl M et al (2009) High insulin levels in newly diagnosed breast cancer patients reflect underlying insulin resistance and are associated with components of the insulin resistance syndrome. Breast Cancer Res Treat 114:517-525. doi:10.1007/s10549-008-0019-0
60. Friedenreich CM, Cust AE (2008) Physical activity and breast cancer risk: impact of timing, type and dose of activity and population subgroup effects. Br J Sports Med 42:636-647. doi:10.1136/bjsm.2006.029132
61. Monninkhof EM, Elias SG, Vlems FA et al (2007) Physical activity and breast cancer: a systematic review. Epidemiology 18:137-157. doi:10.1097/01.ede.0000251167.75581.98 (Pubitemid 46005918)
62. Peters TM, Schatzkin A, Gierach GL et al (2009) Physical activity and postmenopausal breast cancer risk in the NIH-AARP diet and health study. Cancer Epidemiol Biomarkers Prev 18:289-296. doi:10.1158/1055-9965. EPI-08-0768
63. Kellen E, Vansant G, Christiaens MR, Neven P, Van Limbergen E (2009) Lifestyle changes and breast cancer prognosis: a review. Breast Cancer Res Treat 114:13-22. doi:10.1007/s10549-008-9990-8
64. Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA (2005) Physical activity and survival after breast cancer diagnosis. JAMA 293:2479-2486. doi:10.1001/jama.293.20.2479 (Pubitemid 40705729)
65. Holick CN, Newcomb PA, Trentham-Dietz A et al (2008) Physical activity and survival after diagnosis of invasive breast cancer. Cancer Epidemiol Biomarkers Prev 17:379-386. doi:10.1158/1055-9965. EPI-07-0771
66. Abrahamson PE, Gammon MD, Lund MJ et al (2006) Recreational physical activity and survival among young women with breast cancer. Cancer 107:1777-1785. doi:10.1002/cncr.22201 (Pubitemid 44582946)
67. Enger SM, Bernstein L (2004) Exercise activity, body size and premenopausal breast cancer survival. Br J Cancer 90:2138-2141
68. Pierce JP, Stefanick ML, Flatt SW et al (2007) Greater survival after breast cancer in physically active women with high vegetable-fruit intake regardless of obesity. J Clin Oncol 25:2345-2351. doi: 10.1200/JCO.2006.08.6819 (Pubitemid 46999205)
69. Neilson HK, Friedenreich CM, Brockton NT, Millikan RC (2009) Physical activity and postmenopausal breast cancer: proposed biologic mechanisms and areas for future research. Cancer Epidemiol Biomarkers Prev 18:11-27. doi:10.1158/1055-9965. EPI-08-0756
70. Thiebaut AC, Kipnis V, Schatzkin A, Freedman LS (2008) The role of dietary measurement error in investigating the hypothesized link between dietary fat intake and breast cancer-a story with twists and turns. Cancer Invest 26:68-73. doi:10.1080/07357900701527918
71. Rock CL, Demark-Wahnefried W (2002) Nutrition and survival after the diagnosis of breast cancer: a review of the evidence. J Clin Oncol 20:3302-3316. doi:10.1200/JCO.2002.03.008 (Pubitemid 34831528)
72. Holm LE, Nordevang E, Hjalmar ML, Lidbrink E, Callmer E, Nilsson B (1993) Treatment failure and dietary habits in women with breast cancer. J Natl Cancer Inst 85:32-36. doi:10.1093/jnci/85.1.32 (Pubitemid 23023220)
73. Holmes MD, Stampfer MJ, Colditz GA, Rosner B, Hunter DJ, Willett WC (1999) Dietary factors and the survival of women with breast carcinoma. Cancer 86:826-835. doi: 10.1002/(SICI) 1097-0142 (19990901) 86:5<826::AID- CNCR19>3.0.CO;2-0
74. Pierce JP, Natarajan L, Caan BJ et al (2007) Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial. JAMA 298:289-298. doi:10.1001/jama.298.3.289 (Pubitemid 47080483)
75. Gold EB, Pierce JP, Natarajan L et al (2009) Dietary pattern influences breast cancer prognosis in women without hot flashes: the Women's Healthy Eating and Living Trial. J Clin Oncol 27:352-359. doi:10.1200/JCO.2008.16.1067
76. Berrino F, Bellati C, Secreto G et al (2001) Reducing bioavailable sex hormones through a comprehensive change in diet: the diet and androgens (DIANA) randomized trial. Cancer Epidemiol Biomarkers Prev 10:25-33
77. Kaaks R, Bellati C, Venturelli E et al (2003) Effects of dietary intervention on IGF-I and IGF-binding proteins, and related alterations in sex steroid metabolism: the Diet and Androgens (DIANA) Randomised Trial. Eur J Clin Nutr 57:1079-1088. doi: 10.1038/sj.ejcn. 1601647
78. Serra-Majem L, Roman B, Estruch R (2006) Scientific evidence of interventions using the Mediterranean diet: a systematic review. Nutr Rev 64: S27-S47. doi:10.1111/j.1753-4887.2006.tb00232.x
79. Esposito K, Marfella R, Ciotola M et al (2004) Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 292:1440-1446. doi:10.1001/jama.292.12.1440 (Pubitemid 39258336)